Alpha Signal Monitor - Daily Market Briefing | October 13, 2025
Daily Market Research Report
October 13, 2025
Alpha Signal Monitor
Welcome to your daily pre-market briefing. This report provides key insights on market opportunities and analyst perspectives to help identify potential alpha signals.
Today's Coverage: - IPO Calendar: Upcoming initial public offerings and market debuts - Stock Ratings: Latest analyst ratings and target prices for our watchlist
Watchlist Stocks: AAPL, MSFT, GOOGL, AMZN, NVDA, META, TSLA
This report is generated using advanced AI research capabilities with real-time market data access.
Here’s a concise, newsletter-ready US IPO calendar for the coming month. All items reflect the latest public filings and roadshow disclosures as of October 13, 2025; timing and terms can change quickly, especially given ongoing SEC staffing constraints during the federal shutdown.
US IPO Calendar: November 2025 (as of Oct 13, 2025)
| Company (Ticker) | Expected Listing Date | Price Range / Shares | Exchange | Lead underwriters | What the company does |
|---|---|---|---|---|---|
| Wealthfront (WLTH) | TBD (targeting November) | TBD | Nasdaq | Goldman Sachs; J.P. Morgan (additional bookrunners include Citi, Wells Fargo, RBC) | Robo‑advisor and digital wealth platform (cash, ETFs/bonds, loans) serving ~1.3M clients; filed S‑1 Sept 29. (prnewswire.com) |
| BitGo Holdings (BTGO) | TBD (targeting November) | TBD | NYSE | TBD (not disclosed in initial S‑1) | Crypto‑asset custodian for institutions; public S‑1 filed Sept 19 to list as “BTGO.” (sec.gov) |
| BillionToOne (BLLN) | TBD (targeting November) | TBD | Nasdaq | J.P. Morgan; Wells Fargo; William Blair | Molecular diagnostics (non‑invasive prenatal screening; liquid biopsy). (reuters.com) |
| Evommune (EVMN) | TBD (targeting November) | TBD (filed for up to $100M) | NYSE | Morgan Stanley; Leerink Partners; Evercore ISI; Cantor | Phase 2 biotech developing therapies for chronic inflammatory diseases (e.g., MRGPRX2 antagonist for chronic spontaneous urticaria). (renaissancecapital.com) |
| Central Bancompany (CBC) | TBD (targeting November) | TBD | Nasdaq | Morgan Stanley; Keefe, Bruyette & Woods | Bank holding company for Central Trust Bank; $19.1B in assets, wealth advisory footprint across MO/KS/OK/CO; S‑1 filed Oct 10. (reuters.com) |
| Heartflow (HTFL) | TBD (Q4 window; watching November) | TBD | Nasdaq | J.P. Morgan; Morgan Stanley; Piper Sandler | AI‑powered 3D heart modeling to help detect blockages; active S‑1 on file. (reuters.com) |
On the radar (could slip into or out of November based on market/SEC timing)
- Navan (NAVN) — Corporate travel and expense platform. Set IPO terms Oct 10 at $24–$26 for 36.9M shares (Nasdaq), implying ~$6.9B midpoint valuation. If pricing is delayed by SEC timing, this could land in early November. Joint bookrunners led by Goldman Sachs and Citi. (renaissancecapital.com)
- MapLight Therapeutics (MPLT) — CNS‑focused biotech marketing a fixed $17/share deal for 14.75M shares (Nasdaq). Currently slated for late October; any delay would push into early November. Underwriters include Morgan Stanley, Jefferies, Leerink Partners, Stifel. (reuters.com)
Notes and context
- The SEC has allowed certain IPOs to proceed using automatic effectiveness during the government shutdown; calendars may change with little notice. Please confirm final pricing/launch with the syndicate and exchange on the week of listing. (reuters.com)
- This calendar focuses on operating‑company IPOs. SPACs and very small micro‑cap listings are excluded unless specifically requested.
Want this as a living calendar?
- I can refresh this each Friday with any new S‑1s, updated ranges/share counts, and roadshow launches so your newsletter always captures the latest week‑ahead.
Stock Ratings — Big 6 US Banks – Latest Targets and Ratings for Mega-Cap Tech (as of 2025-10-13)
Pulled from recent bank notes and reliable news summaries. Targets are 12‑month unless noted. Ratings use each bank’s own scale (e.g., Overweight/Equal Weight/Underweight).
AAPL - Apple Inc.
Across the six banks, Apple skews positive with 6/6 Buy/Overweight-equivalent calls; most recent moves were upward from MS and reaffirmations from WFC.
| Institution | Rating | Target Price | Last Update | Notes |
|---|---|---|---|---|
| Goldman Sachs | Buy | $280 | 2025-01-23 | GS trimmed PT to $280 while maintaining Buy. Source: Investing.com article on 2025-01-23. |
| Morgan Stanley | Overweight | $298 | 2025-10-02 | MS raised Apple PT to $298, maintained Overweight. Source: GuruFocus summary of MS note on 2025-10-02. |
| JP Morgan | Overweight | $270 | 2025-01-31 | JPM lifted PT to $270, stayed Overweight; later notes maintained level. |
| Bank of America | Buy | $260 | 2025-09-03 | BofA raised PT to $260 while keeping Buy. Source: MarketBeat/ABMN item dated 2025-09-03. |
| Citigroup | Buy | $240 | 2025-05-02 | Citi maintained Buy; PT set at $240 in early May. |
| Wells Fargo | Overweight | $245 | 2025-08-07 | WFC reiterated Overweight, $245 PT after US investment update. |
Consensus View - Rating: Buy, Target Price: $265.50 - Average of six PTs; broad Buy/Overweight skew.
MSFT - Microsoft Corp.
Very strong unanimity; all six institutions at Buy/Overweight with multiple PT hikes into late Q3/Q4.
| Institution | Rating | Target Price | Last Update | Notes |
|---|---|---|---|---|
| Goldman Sachs | Buy | $500 | 2025-01-30 | GS reiterated Buy, $500 PT post-FQ2 FY25. |
| Morgan Stanley | Overweight | $625 | 2025-09-26 | MS raised PT to $625 (top pick). |
| JP Morgan | Overweight | $475 | 2025-05-01 | JPM raised PT to $475, remained Overweight. |
| Bank of America | Buy | $585 | 2025-07-18 | BofA lifted PT to $585, reiterated Buy. |
| Citigroup | Buy | $540 | 2025-05-15 | Citi raised PT to $540, kept Buy. |
| Wells Fargo | Overweight | $675 | 2025-10-06 | WFC boosted PT to $675, stayed Overweight. |
Consensus View - Rating: Buy, Target Price: $566.67 - Highest big-bank consensus after META; unanimous bullish stance.
GOOGL - Alphabet Inc.
Lean-positive: 5 Buy/Overweight vs. 1 Equal Weight; targets cluster around ~$210.
| Institution | Rating | Target Price | Last Update | Notes |
|---|---|---|---|---|
| Goldman Sachs | Buy | $234 | 2025-09-03 | GS reiterated Buy and $234 PT after antitrust remedies decision. |
| Morgan Stanley | Overweight | $270 | 2025-10-02 | MS lifted PT to $270, maintained Overweight. |
| JP Morgan | Overweight | $195 | 2025-05-21 | JPM maintained Overweight, $195 PT post Google I/O. |
| Bank of America | Buy | $185 | 2025-04-09 | BofA kept Buy; PT $185 in April traffic/engagement check. |
| Citigroup | Buy | $200 | 2025-05-21 | Citi maintained Buy, $200 PT; reiterated post I/O. |
| Wells Fargo | Equal Weight | $175 | 2025-05-21 | WFC Equal Weight with $175 PT; coverage maintained 2025-10-07. |
Consensus View - Rating: Buy, Target Price: $209.83 - Average PT ~ $210 with broadly constructive outlooks.
AMZN - Amazon.com Inc.
All six are Buy/Overweight; several raised targets mid–late 2025 on AWS reacceleration.
| Institution | Rating | Target Price | Last Update | Notes |
|---|---|---|---|---|
| Goldman Sachs | Buy | $275 | 2025-10-03 | GS raised PT to $275, remained Buy. |
| Morgan Stanley | Overweight | $300 | 2025-07-11 | MS boosted PT to $300, kept Overweight (AWS acceleration). |
| JP Morgan | Overweight | $225 | 2025-05-02 | JPM maintained Overweight, $225 PT post‑earnings. |
| Bank of America | Buy | $272 | 2025-08-01 | BofA raised PT to $272, stayed Buy. |
| Citigroup | Buy | $265 | 2025-07-22 | Citi raised PT to $265 ahead of Q2, maintained Buy. |
| Wells Fargo | Overweight | $280 | 2025-09-24 | WFC upgraded to Overweight; PT lifted to $280 on AWS outlook. |
Consensus View - Rating: Buy, Target Price: $269.50 - Average PT near $270; constructive on AWS-driven acceleration.
NVDA - NVIDIA Corp.
Unanimous Buy/Overweight with PTs clustered ~$200–$235; multiple banks raised into late Q3 on Blackwell/Rubin roadmap.
| Institution | Rating | Target Price | Last Update | Notes |
|---|---|---|---|---|
| Goldman Sachs | Buy | $200 | 2025-08-28 | GS reiterated Buy and $200 PT around earnings cycle. |
| Morgan Stanley | Overweight | $160 | 2025-05-29 | MS maintained Overweight; PT $160 after estimate updates. |
| JP Morgan | Overweight | $215 | 2025-09-04 | JPM raised PT to $215, kept Overweight. |
| Bank of America | Buy | $235 | 2025-08-28 | BofA lifted PT to $235 (top sector pick). |
| Citigroup | Buy | $210 | 2025-09-30 | Citi raised PT to $210 on stronger AI infra spend outlook. |
| Wells Fargo | Overweight | $220 | 2025-09-11 | WFC hiked PT to $220 in Aug; maintained in Sept. |
Consensus View - Rating: Buy, Target Price: $206.67 - Average from six PTs; banks broadly positive on datacenter cycle.
META - Meta Platforms Inc.
Strongest upside profile of the group; all six at Buy/Overweight and four PTs ≥ $800.
| Institution | Rating | Target Price | Last Update | Notes |
|---|---|---|---|---|
| Goldman Sachs | Buy | $690 | 2025-05-01 | GS reiterated Buy; PT nudged to $690 in May (prior Jan +$765). |
| Morgan Stanley | Overweight | $850 | 2025-07-31 | MS raised PT to $850 on AI engagement/monetization. |
| JP Morgan | Overweight | $875 | 2025-07-31 | JPM lifted PT to $875 after strong Q2 guide. |
| Bank of America | Buy | $900 | 2025-09-09 | BofA maintained $900 PT ahead of Connect; Buy. |
| Citigroup | Buy | $803 | 2025-06-24 | Citi raised PT to $803; reiterated Top Pick into Q2. |
| Wells Fargo | Overweight | $783 | - | WFC recently raised PT (reported ~Aug 2025) and models >$27 2025 EPS; article cites $783 target. |
Consensus View - Rating: Buy, Target Price: $816.83 - Average PT ≈ $817; unanimous Buy/OW posture.
TSLA - Tesla Inc.
Views are split: 1 Overweight, 3 Neutral/Equivalent, 2 Underweight. PTs range widely ($120–$410) with a modest ~$255 average.
| Institution | Rating | Target Price | Last Update | Notes |
|---|---|---|---|---|
| Goldman Sachs | Neutral | $395 | 2025-09-18 | GS raised PT to $395; rating stays Neutral. |
| Morgan Stanley | Overweight | $410 | 2025-08-04 | MS reiterated Overweight; $410 PT in August note (previously $430 earlier in 2025). |
| JP Morgan | Underweight | $120 | 2025-03-12 | JPM cut PT to $120; remained Underweight on delivery risks. |
| Bank of America | Neutral | $305 | 2025-04-23 | BofA kept Neutral; $305 PT post Q1 results (earlier cuts from $490 → $380 cited). |
| Citigroup | Neutral | $180 | - | Citi trimmed PT to ~$180 (from $196) around early April; Neutral. Sourced via Investing.com/TheFly roundups. |
| Wells Fargo | Underweight | $120 | 2025-07-10 | WFC reiterated Underweight; $120 PT into Q2. Prior cuts to $130 also noted. |
Consensus View - Rating: Hold, Target Price: $255.00 - Average reflects split views; only MS is OW while JPM/WFC stay UW.
Highlights
- META shows the highest big-bank consensus target (~$817) with all six at Buy/Overweight.
- MSFT consensus (~$567) is second-highest and unanimously positive across all banks.
- TSLA has the widest dispersion: UW calls and $120 PTs (JPM/WFC) versus OW at MS and a $395 Neutral at GS.
- NVDA targets cluster ~$200–$235 with multiple late‑Q3 raises (Citi $210, WFC $220, BofA $235).
- AMZN saw late‑Q3 upgrades/hikes (MS to $300; WFC to $280) on AWS reacceleration.
Notes: Some banks publish behind paywalls; where necessary, reputable secondary summaries (Investing.com, Reuters, Barron’s, Nasdaq/Fintel, GuruFocus, MarketBeat/ABMN) were cited. Dates reflect the most recent verifiable items per institution/stock. If you want this refreshed after the next earnings cycle, say “refresh after earnings” and I’ll update all entries.
Disclaimer
This research report is for informational purposes only and does not constitute investment advice. All information is sourced from publicly available data and should be verified independently. Past performance does not guarantee future results.
Generated on: 2025-10-13 at 11:11 UTC
Source: Alpha Signal Monitor - Automated Research System
Contact: For questions about this report, please contact your Alpha Signal Monitor administrator.
Powered by Alpha Signal Monitor | Market Intelligence Through AI